Prophylaxis for Spontaneous Bacterial Peritonitis (SBP)
Introduction to Prophylaxis
- The European Association for the Study of the Liver recommends norfloxacin 400 mg daily for high-risk patients with ascitic fluid protein <15 g/L and advanced liver disease, defined by a Child-Pugh score ≥9 points or impaired renal function 4, 1, 2
- Norfloxacin 400 mg once daily is the first-line prophylactic antibiotic for both primary and secondary prevention of SBP in cirrhotic patients with ascites, with ciprofloxacin 500 mg daily or co-trimoxazole as acceptable alternatives 1, 2, 3
Secondary Prophylaxis
- All patients who have recovered from an episode of SBP must receive continuous prophylaxis indefinitely until liver transplantation or resolution of ascites 1, 2, 3
- Norfloxacin 400 mg once daily reduces recurrence from approximately 70% to 20% at one year and improves 3-month survival from 62% to 94% 1, 2
- Alternative options include ciprofloxacin 500 mg once daily 1, 3 and co-trimoxazole (800 mg sulfamethoxazole/160 mg trimethoprim) once daily 1
Primary Prophylaxis
- Primary prophylaxis is indicated for high-risk patients, including those with ascitic fluid protein <15 g/L and advanced liver disease 4
- Norfloxacin reduces the 1-year probability of developing SBP from 61% to 7% in high-risk patients 2, 3
- The American Association for the Study of Liver Diseases supports primary prophylaxis for patients with ascitic fluid protein <1.5 g/dL plus impaired renal function or liver failure 4
Prophylaxis During Acute Gastrointestinal Bleeding
- All cirrhotic patients with acute GI bleeding require antibiotic prophylaxis, as bacterial infections occur in 25-65% of these patients 2, 3
- Advanced liver disease (Child-Pugh B/C) requires IV ceftriaxone 1g daily for 7 days, while less severe disease can be treated with norfloxacin 400 mg orally twice daily for 7 days 2, 3
Antibiotic Selection and Alternatives
- Norfloxacin 400 mg once daily is the most extensively studied agent with the strongest evidence base 1, 3
- Ciprofloxacin 500 mg once daily is an acceptable alternative 1, 3
- Co-trimoxazole (800/160 mg) once daily has similar efficacy to norfloxacin but may have increased adverse events 1
Critical Monitoring and Pitfalls
- Long-term quinolone prophylaxis increases risk of gram-positive infections and multidrug-resistant organisms 1, 2, 3
- Regular renal function monitoring is essential in patients on prophylactic antibiotics 1, 2
- Monitor for tendon pain or inflammation (fluoroquinolone side effect) and discontinue at first sign 1, 2
- Restrict proton pump inhibitor (PPI) use in cirrhotic patients, as PPIs may increase SBP risk 1, 2